Literature DB >> 15335425

Decreases in ventricular volume correlate with decreases in ventricular pressure in idiopathic normal pressure hydrocephalus patients who experienced clinical improvement after implantation with adjustable valve shunts.

Kathleen A McConnell1, Kelly H Zou, Alexandra V Chabrerie, Nancy Olsen Bailey, Peter McL Black.   

Abstract

OBJECTIVE: This retrospective study examined whether changes in ventricular volume correspond with changes in adjustable valve pressure settings in a cohort of patients who received shunts to treat idiopathic normal pressure hydrocephalus. We also examined whether these pressure-volume curves and other patient variables would co-occur with a positive clinical response to shunting.
METHODS: We selected 51 patients diagnosed with idiopathic normal pressure hydrocephalus who had undergone implantation of a Codman Hakim programmable valve (Medos S.A., Le Locle, Switzerland). Clinical data were gathered from the patients' records and clinical notes by an investigator blinded to patients' ventricular volumes. Ventricular volume was measured using 3D Slicer, an image analysis and interactive visualization software package developed and maintained at the Surgical Planning Laboratory at Brigham and Women's Hospital.
RESULTS: Eighty-six percent of patients with gait disturbance at presentation showed improvement of this symptom, 70% experienced improvement in incontinence, and 69% experienced improvement in dementia. For the group showing 100% clinical improvement, the correlation coefficient of average changes in valve pressure over time (delta P/delta T) and average changes in ventricular volume over time (delta V/delta T) were high at 0.843 (P < 0.05). For the group experiencing no or only partial improvement, the correlation coefficient was 0.257 (P = 0.32), indicating no correlation between average delta V/delta T and average delta P/delta T for each patient.
CONCLUSION: This was a carefully analyzed modeling study of idiopathic normal pressure hydrocephalus treatment made possible only by adjustable valve technology. With careful volumetric analysis, we found that changes in ventricular volume correlated with adjustments in valve pressure settings for those patients who improved clinically after shunting. This suggests that positive clinical responders retained parenchymal elasticity, emphasizing the importance of dynamic changes in this cohort.

Entities:  

Mesh:

Year:  2004        PMID: 15335425      PMCID: PMC1350579          DOI: 10.1227/01.neu.0000134385.23401.01

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  25 in total

1.  Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients.

Authors:  G Zemack; B Romner
Journal:  J Neurosurg       Date:  2000-06       Impact factor: 5.115

2.  Does the shunt opening pressure influence the effect of shunt surgery in normal pressure hydrocephalus?

Authors:  A Larsson; C Jensen; M Bilting; S Ekholm; H Stephensen; C Wikkelsö
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the so-called "normal pressure hydrocephalus" syndrome.

Authors:  J Sahuquillo; E Rubio; A Codina; A Molins; J M Guitart; M A Poca; A Chasampi
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  The role of cerebrospinal compensatory parameters in the estimation of functioning of implanted shunt system in patients with communicating hydrocephalus (preliminary report).

Authors:  W Maksymowicz; M Czosnyka; W Koszewski; A Szymanska; W Traczewski
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 5.  Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome.

Authors:  A O Hebb; M D Cusimano
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

6.  Incidence and management of subdural hematoma/hygroma with variable- and fixed-pressure differential valves: a randomized, controlled study of programmable compared with conventional valves.

Authors:  P W Carmel; A L Albright; P D Adelson; A Canady; P Black; W Boydston; D Kneirim; B Kaufman; M Walker; M Luciano; I F Pollack; K Manwaring; M P Heilbrun; I R Abbott; H Rekate
Journal:  Neurosurg Focus       Date:  1999-10-15       Impact factor: 4.047

7.  Reduction of ventricular size after shunting for normal pressure hydrocephalus related to CSF dynamics before shunting.

Authors:  J T Tans; D C Poortvliet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

8.  The preselection value of the Doppler LP test for shunt-therapy in patients with normal pressure hydrocephalus.

Authors:  H C Schoonderwaldt; G Cho Chia Yuen; E J Colon; O R Hommes; S L Notermans; H A Walder
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

Review 9.  Normal pressure hydrocephalus and dementia--evaluation and treatment.

Authors:  D A Turner; R E McGeachie
Journal:  Clin Geriatr Med       Date:  1988-11       Impact factor: 3.076

10.  Normal-pressure hydrocephalus: diagnosis and patient selection for shunt surgery.

Authors:  J H Wood; D Bartlet; A E James; G B Udvarhelyi
Journal:  Neurology       Date:  1974-06       Impact factor: 9.910

View more
  2 in total

1.  3D mapping of cerebrospinal fluid local volume changes in patients with hydrocephalus treated by surgery: preliminary study.

Authors:  Jérôme Hodel; Pierre Besson; Alain Rahmouni; Eric Petit; Alain Lebret; Bénédicte Grandjacques; Olivier Outteryck; Mohamed Amine Benadjaoud; Anne Maraval; Alain Luciani; Jean-Pierre Pruvo; Philippe Decq; Xavier Leclerc
Journal:  Eur Radiol       Date:  2013-08-27       Impact factor: 5.315

2.  Association between improvement of clinical signs and decrease of ventricular volume after ventriculoperitoneal shunting in dogs with internal hydrocephalus.

Authors:  Martin J Schmidt; Antje Hartmann; Daniela Farke; Klaus Failling; Malgorzata Kolecka
Journal:  J Vet Intern Med       Date:  2019-04-08       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.